AW
RCKT icon

Avion Wealth’s Rocket Pharmaceuticals RCKT Stock Holding History

Avion Wealth’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-291
Closed -$1K – 1677
2026
Q1 		$1K Buy
291
+158
+119% +$628 ﹤0.01% 1118
2025
Q4 		$0 Buy
+133
New +$455 ﹤0.01% 1527
2025
Q2 		– Sell
-146
Closed -$1K – 1531
2025
Q1 		$1K Hold
146
– – ﹤0.01% 914
2024
Q4 		$1K Buy
+146
New +$2.2K ﹤0.01% 911

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Avion Wealth's RCKT Position: Q2 2026 in Review

Avion Wealth sold out of Rocket Pharmaceuticals (RCKT) in Q2 2026, closing a stake of 291 shares — an estimated $1K sold.

Avion Wealth first reported a position in RCKT in Q4 2024 and held it in 4 quarters. The position peaked at $1K in Q1 2026. 180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Avion Wealth reported no remaining Rocket Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Avion Wealth sold 291 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1K.
  • Avion Wealth first reported a position in Rocket Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Avion Wealth's Rocket Pharmaceuticals position peaked at $1K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on Avion Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.